HomeCompareKLBAY vs MRK

KLBAY vs MRK: Dividend Comparison 2026

KLBAY yields 4.61% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KLBAY wins by $3895.52M in total portfolio value
10 years
KLBAY
KLBAY
● Live price
4.61%
Share price
$7.54
Annual div
$0.35
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3895.58M
Annual income
$3,739,671,301.48
Full KLBAY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KLBAY vs MRK

📍 KLBAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKLBAYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KLBAY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KLBAY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KLBAY
Annual income on $10K today (after 15% tax)
$391.67/yr
After 10yr DRIP, annual income (after tax)
$3,178,720,606.26/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KLBAY beats the other by $3,178,712,277.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KLBAY + MRK for your $10,000?

KLBAY: 50%MRK: 50%
100% MRK50/50100% KLBAY
Portfolio after 10yr
$1947.82M
Annual income
$1,869,840,549.81/yr
Blended yield
96.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KLBAY
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
2.2
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KLBAY buys
0
MRK buys
0
No recent congressional trades found for KLBAY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKLBAYMRK
Forward yield4.61%2.76%
Annual dividend / share$0.35$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$3895.58M$56.8K
Annual income after 10y$3,739,671,301.48$9,798.13
Total dividends collected$3884.57M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: KLBAY vs MRK ($10,000, DRIP)

YearKLBAY PortfolioKLBAY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,622$921.56$11,206$366.19+$416.00KLBAY
2$14,437$2,001.87$12,650$502.35+$1.8KKLBAY
3$20,096$4,648.30$14,407$694.19+$5.7KKLBAY
4$33,597$12,094.02$16,585$967.82+$17.0KKLBAY
5$73,741$37,792.50$19,342$1,363.89+$54.4KKLBAY
6$233,950$155,047.58$22,913$1,947.19+$211.0KKLBAY
7$1,169,774$919,447.21$27,662$2,823.89+$1.14MKLBAY
8$9,844,790$8,593,131.36$34,159$4,173.35+$9.81MKLBAY
9$145,710,720$135,176,795.03$43,337$6,308.80+$145.67MKLBAY
10$3,895,581,772$3,739,671,301.48$56,776$9,798.13+$3895.52MKLBAY

KLBAY vs MRK: Complete Analysis 2026

KLBAYStock

Klabin S.A., together with its subsidiaries, operates in the paper and pulp industry in Brazil and internationally. It operates through Forestry, Paper, Conversion, and Pulp segments. The Forestry segment engages in the planting and forestry operations of pine and eucalyptus; and sale of wood logs. The Paper segment produces and sells reels of cardboard, kraftliner, and recycled paper. The Conversion segment is involved in the production and sale of corrugated boxes and sheets, and industrial bags. The Pulp segment produces and sells short, long, and fluffed pulp. The company also engages in the reforestation business; manufacture of phytotherapic products; and hotel business. In addition, it provides port, packaging customization, and finance services, as well as invests in other companies. Klabin S.A. was founded in 1899 and is headquartered in São Paulo, Brazil.

Full KLBAY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KLBAY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KLBAY vs SCHDKLBAY vs JEPIKLBAY vs OKLBAY vs KOKLBAY vs MAINKLBAY vs JNJKLBAY vs ABBVKLBAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.